ScholarIQanswers from OpenAlex

Transglutaminase 2 in breast cancer metastasis and drug resistance

PaperCitations, authors & open-access status

Transglutaminase 2 in breast cancer metastasis and drug resistance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transglutaminase 2 in breast cancer metastasis and drug resistance have?

ScholarIQcitation count

Transglutaminase 2 in breast cancer metastasis and drug resistance has 9 citations in the OpenAlex counts ScholarIQ stores.

When was Transglutaminase 2 in breast cancer metastasis and drug resistance published?

ScholarIQyear

Transglutaminase 2 in breast cancer metastasis and drug resistance has 2024 year in the ScholarIQ index.

What is the open-access status of Transglutaminase 2 in breast cancer metastasis and drug resistance?

ScholarIQoa status

Transglutaminase 2 in breast cancer metastasis and drug resistance has gold oa status in the ScholarIQ index.

What is the DOI of Transglutaminase 2 in breast cancer metastasis and drug resistance?

ScholarIQdoi

The DOI for Transglutaminase 2 in breast cancer metastasis and drug resistance is on the source record.

What is the PMID of Transglutaminase 2 in breast cancer metastasis and drug resistance?

ScholarIQpmid

The PMID for Transglutaminase 2 in breast cancer metastasis and drug resistance is on the source record.

What is the OpenAlex record for Transglutaminase 2 in breast cancer metastasis and drug resistance?

ScholarIQopenalex

The OpenAlex for Transglutaminase 2 in breast cancer metastasis and drug resistance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial